(Total Views: 951)
Posted On: 07/27/2020 12:16:02 AM
Post# of 153917
Regeneron has a drug that started human trials (i think Phase 2), June 11.... REGN-COV2.... not sure why nobody’s talking about that one.... almost certainly will be addressed by Trump (Govt already purchased their first available 300k doses, presumably with insight to their results)..
they’d easily have results by now. Probably can crunch the #s and present the data most quickly as well...ugh
However, I think Cytodyn Mgmt is more savvy than the Armchair CEOs would give them credit for.. and aren’t telling us everything big picture.. I sure hope they’re getting us in with the FDA and Administration. Our EINDs and trials are small fries but hopefully the results show dramatic impact, the science is validated & we can’t be denied. We’ll sell out & even scale up considerably. Regardless of REG-COV2.
But given their securing the investment (as if they need it lol)... id give Regeneron a leg up vs us at this point until the data is released — either showing their drug marginally effective (likely) or Leronlimab highly effective.
they’d easily have results by now. Probably can crunch the #s and present the data most quickly as well...ugh
However, I think Cytodyn Mgmt is more savvy than the Armchair CEOs would give them credit for.. and aren’t telling us everything big picture.. I sure hope they’re getting us in with the FDA and Administration. Our EINDs and trials are small fries but hopefully the results show dramatic impact, the science is validated & we can’t be denied. We’ll sell out & even scale up considerably. Regardless of REG-COV2.
But given their securing the investment (as if they need it lol)... id give Regeneron a leg up vs us at this point until the data is released — either showing their drug marginally effective (likely) or Leronlimab highly effective.
(1)
(0)
